- Home
- OST vs GTBP Comparison
OST vs GTBP Comparison
Compare OST & GTBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OST
- GTBP
- Stock Information
- Founded
- OST 2010
- GTBP 1965
- Country
- OST China
- GTBP United States
- Employees
- OST N/A
- GTBP N/A
- Industry
- OST Industrial Machinery/Components
- GTBP Biotechnology: Pharmaceutical Preparations
- Sector
- OST Technology
- GTBP Health Care
- Exchange
- OST Nasdaq
- GTBP Nasdaq
- Market Cap
- OST 5.7M
- GTBP 4.8M
- IPO Year
- OST 2022
- GTBP N/A
- Fundamental
- Price
- OST $0.41
- GTBP $2.11
- Analyst Decision
- OST
- GTBP
- Analyst Count
- OST 0
- GTBP 0
- Target Price
- OST N/A
- GTBP N/A
- AVG Volume (30 Days)
- OST 83.1K
- GTBP 15.4K
- Earning Date
- OST 08-26-2024
- GTBP 10-30-2024
- Dividend Yield
- OST N/A
- GTBP N/A
- EPS Growth
- OST N/A
- GTBP N/A
- EPS
- OST N/A
- GTBP N/A
- Revenue
- OST $38,203,634.00
- GTBP N/A
- Revenue This Year
- OST N/A
- GTBP N/A
- Revenue Next Year
- OST N/A
- GTBP N/A
- P/E Ratio
- OST N/A
- GTBP N/A
- Revenue Growth
- OST N/A
- GTBP N/A
- 52 Week Low
- OST $0.27
- GTBP $1.92
- 52 Week High
- OST $1.07
- GTBP $10.66
- Technical
- Relative Strength Index (RSI)
- OST 61.31
- GTBP 50.71
- Support Level
- OST $0.38
- GTBP $1.95
- Resistance Level
- OST $0.44
- GTBP $2.18
- Average True Range (ATR)
- OST 0.04
- GTBP 0.16
- MACD
- OST 0.00
- GTBP 0.00
- Stochastic Oscillator
- OST 77.14
- GTBP 18.94
About OST Ostin Technology Group Co. Ltd.
Ostin Technology Group Co Ltd is a supplier of display modules and polarizers in China. It designs, develops, and manufactures TFT-LCD modules in a wide range of sizes and customized sizes according to the specifications of its customers. Its display modules are mainly used in consumer electronics, commercial LCD displays, and automotive displays. The company also manufactures polarizers used in the TFT-LCD display modules and is in the process of developing polarizers for the OLED display panel. Geographically, the company generates revenue from Hong Kong, Taiwan, and Mainland China which is its key revenue generating market.
About GTBP GT Biopharma Inc.
GT Biopharma Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immuno-oncology products in the United States. It is engaged in discovering, developing, and commercializing novel therapeutics from its proprietary product platform in a varied range of disease areas. The company mainly develops drugs focused on the treatment of cancer. Its TriKE (Tri-specific Killer Engager) platforms offer immuno-oncology products that can treat a range of hematologic malignancies, sarcoma, and solid tumors.